Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial
T. M. L. Tong, Mark C. Burgmans, Frank M. Speetjens, Arian R. van Erkel, R.W. van der Meer, C. S. P. van Rijswijk, M. A. Jonker-Bos, C. F. M. Roozen, M. Sporrel-Blokland, Jacob Lutjeboer, Els L. van Persijn van Meerten, Chris H. Martini, R. W. M. Zoethout, Fred G. J. Tijl, Christian U. Blank, Ellen Kapiteijn
Topics & Concepts
MedicineCommon Terminology Criteria for Adverse EventsIpilimumabInternal medicineNivolumabCohortAdverse effectNeutropeniaGastroenterologyResponse Evaluation Criteria in Solid TumorsSurgeryCancerChemotherapyPhases of clinical researchImmunotherapyOcular Oncology and TreatmentsOcular Disorders and TreatmentsAutoimmune Neurological Disorders and Treatments